Home - Cognis Group Blog

AI versus Humans: The Salient Issue of Our Time

December 4, 2020

In partnership with Techcast. For more information, sign up at https://BillHalal.com Overview This brief focuses on the other cognitive functions that should be included in the exploration of the role AI will

Development of therapeutic agents for neurodegenerative disease through improvement of phagocytosis through NCKAP1 regulation

November 16, 2020

Featured Technologies

Opportunity ContactJames Noh, CEOSeoul, South Korea Hanyang University Website Pharmalicensing.com Development of customized treatments for neurodegenerative disease focused on immune-inflammatory modulation through novel use of NCKAP1 in the regulation of microglial cell

Development of BBB-penetrating Peptide, DNP2, Based CTLA-4 Drug Candidate for Inducing Regulatory T Cells in Multiple Sclerosis

November 15, 2020

Featured Technologies

Opportunity ContactJames Noh, CEOSeoul, South Korea Hanyang University Website Pharmalicensing.com We identify a cell-permeable peptide, dNP2, which efficiently delivers proteins into mouse and human T cells, as well as various tissues. Introduction/BackgroundWe

Medical Suction Unit with Constant Suction Pressure

November 15, 2020

Featured Technologies

Opportunity ContactJames Noh, CEOSeoul, South Korea Hanyang University Website Pharmalicensing.com The present invention relates to a medical aspirator, and more particularly, to a device for draining blood or exudate generated in a

Bio-Patch

November 14, 2020

Featured Technologies

Opportunity ContactJames Noh, CEOSeoul, South Korea Hanyang University Website Pharmalicensing.com Provide a hydrocolloid-form bio-patch which has warmth keeping ability, air permeability, is waterproof, and improved exudation absorption ability. Description of Technology Technology Green

Discovery of Therapeutic Target Genes for Individual Cancer Patients with a Genome-wide Quantitative Evaluation

November 14, 2020

Featured Technologies

Opportunity ContactJames Noh, CEOSeoul, South Korea Hanyang University Website Pharmalicensing.com A research team from Hanyang University in South Korea has developed a new technology for discovering therapeutic target genes for individual cancer patients with

OBX02-011, Multi-target Kinase Inhibitor for Non-small Cell Lung Cancer (NSCLC) Treatment After Failure of Tagrisso

November 11, 2020

Featured Technologies

Opportunity ContactJames Noh, CEOSeoul, South Korea Oncobix Oncology Biosciences Website Pharmalicensing.com Mutation in the kinase region of the epidermal growth factor receptor (EGFR) is found in some non-small cell lung cancer patients

Speech Gap Test – Novel Automatic Speech Recognition of Mild Cognitive Impairment

November 11, 2020

Featured Technologies

Opportunity ContactEnikő Koppány, Business Development ManagerSzeged, Hungary University of Szeged Website Pharmalicensing.com The recognition of Mild Cognitive Impairment (MCI) is one of the most difficult tasks of clinical psychiatry. Current tests are

Endocytosis Routing Sequence Peptides for Cell Delivery Systems

November 11, 2020

Featured Technologies

Opportunity ContactEnikő Koppány, Business Development ManagerSzeged, Hungary University of Szeged Website Pharmalicensing.com The WYKYW pentapeptide is an endocytosis routing sequence for cell delivery of therapeutic macromolecules at therapeutically relevant nanomolar concentrations and

Using Desethylamiodarone in the Treatment and Prevention of Cardiac Arrhythmias

November 10, 2020

Featured Technologies

Opportunity ContactEnikő Koppány, Business Development ManagerSzeged, Hungary University of Szeged Website Pharmalicensing.com The application of desethamiodarone (DEA) in the treatment of arrhythmias would be more effective than chronic amiodarone (AMIO) treatment with